lncRNA MIAT Regulates Cell Growth, Migration, and Invasion Through Sponging miR-150-5p in Ovarian Cancer
Authors:
- 1 November 2020
- journal article
- research article
- Published by SAGE Publications in Cancer Biotherapy and Radiopharmaceuticals
- Vol. 35 (9) , 650-660
Abstract
Background: MIAT (myocardial infarction-associated transcript) regulates cell proliferation, apoptosis, and metastasis in several cancers. In this study, the authors aimed to explore the role of MIAT in ovarian cancer. Materials and Methods: The expression of MIAT in ovarian cancer subtypes, normal human ovarian surface epithelial and ovarian cancer cell lines was measured by qualitative real-time polymerase chain reaction (qRT-PCR). OVCAR3 and SKOV3 cells were transfected with MIAT overexpression plasmid or siMIAT. The cell growth ability was then evaluated by CCK-8 and colony formation assays. The cell migration and invasion rate were separately measured by wound-healing and transwell assays. The levels of epithelial–mesenchymal transition (EMT)-associated markers were evaluated by western blotting. MIAT sponging miR-150-5p was predicted by starBase and confirmed by dual-luciferase reporter assays. The expression of miR-150-5p in OVCAR3 and SKOV3 cells with MIAT overexpression or knockdown, and in ovarian cancer subtypes was also measured by qRT-PCR. Further analyses confirmed the role of MIAT sponging miR-150-5p in ovarian cancer cells. Results: MIAT was highly expressed in mesenchymal subtype ovarian cancer tissues and ovarian cancer cells. In OVCAR3 and SKOV3 cells, overexpression of MIAT promoted, and knockdown of MIAT suppressed the cell growth, migration, invasion, and EMT. miR-150-5p was sponged and regulated by MIAT. miR-150-5p was downregulated in mesenchymal subtype ovarian cancer. Suppression of cell migration, invasion, and EMT caused by miR-150-5p overexpression was rescued by MIAT overexpression. Conclusions: MIAT acts as an oncogene in ovarian cancer cells through sponging miR-150-5p. MIAT or miR-150-5p expression might be a potential prognostic biomarker for ovarian cancer patients. MIAT and miR-150-5p are potential therapeutic targets in treatment of ovarian cancer.Keywords
This publication has 47 references indexed in Scilit:
- Can advanced-stage ovarian cancer be cured?Nature Reviews Clinical Oncology, 2016
- Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering GlycolysisCell Reports, 2015
- The emerging role of lncRNAs in cancerNature Medicine, 2015
- A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain MetastasisClinical Cancer Research, 2015
- lncRNA-MIAT Regulates Microvascular Dysfunction by Functioning as a Competing Endogenous RNACirculation Research, 2015
- Identification of lncRNA-associated competing triplets reveals global patterns and prognostic markers for cancerNucleic Acids Research, 2015
- MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosisPigment Cell & Melanoma Research, 2015
- RETRACTED: miR-150-5p Inhibits Hepatoma Cell Migration and Invasion by Targeting MMP14PLOS ONE, 2014
- Novel Strategies to Enforce an Epithelial Phenotype in Mesenchymal CellsCancer Research, 2014
- ZNF300P1 Encodes a lincRNA that regulates cell polarity and is epigenetically silenced in type II epithelial ovarian cancerMolecular Cancer, 2014